Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (421-430 of 666) with videos related to

Pageof 67
Sort By:
NEJM Evidence|June 20, 2022
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black MenSpyridon P Basourakos, Roman Gulati, Randy A Vince, et al.
Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.
Advances in Radiation Oncology|July 26, 2017
Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancerRafael Gadia, Elton Trigo Teixeira Leite, Ana Luiza Bierrenbach, et al.
European Urology Oncology|August 7, 2022
Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and MetaregressionMichael Baboudjian, Alberto Breda, Pawel Rajwa, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Cancer Research|October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing RadiationDaniel E Spratt, Michael J Evans, Brian J Davis, et al.
Advances in Radiation Oncology|November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
Prostate Cancer and Prostatic Diseases|December 18, 2019
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare settingLauren E Howard, Jingbin Zhang, Nick Fishbane, et al.
European Urology Open Science|January 13, 2022
<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary TractAlexander S Taylor, Brandon Newell, Arul M Chinnaiyan, et al.
Pageof 67

Showing results (421-430 of 666) with videos related to

Sort By:
Pageof 67
NEJM Evidence|June 20, 2022
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black MenSpyridon P Basourakos, Roman Gulati, Randy A Vince, et al.
Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.
Advances in Radiation Oncology|July 26, 2017
Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancerRafael Gadia, Elton Trigo Teixeira Leite, Ana Luiza Bierrenbach, et al.
European Urology Oncology|August 7, 2022
Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and MetaregressionMichael Baboudjian, Alberto Breda, Pawel Rajwa, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Cancer Research|October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing RadiationDaniel E Spratt, Michael J Evans, Brian J Davis, et al.
Advances in Radiation Oncology|November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2026
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinicPaul J Keall, Jeremy Booth, Thomas Eade, et al.
Prostate Cancer and Prostatic Diseases|December 18, 2019
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare settingLauren E Howard, Jingbin Zhang, Nick Fishbane, et al.
European Urology Open Science|January 13, 2022
<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary TractAlexander S Taylor, Brandon Newell, Arul M Chinnaiyan, et al.
Pageof 67